Table of Contents Author Guidelines Submit a Manuscript
Erratum

An erratum for this article has been published. To view the erratum, please click here.

Evidence-Based Complementary and Alternative Medicine
Volume 2014 (2014), Article ID 621756, 10 pages
http://dx.doi.org/10.1155/2014/621756
Research Article

Ameliorating Adriamycin-Induced Chronic Kidney Disease in Rats by Orally Administrated Cardiotoxin from Naja naja atra Venom

1The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, China
2Department of Pharmacology and Laboratory of Aging and Nervous Diseases, Soochow University School of Medicine, Suzhou 215123, Jiangsu, China
3The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215004, China

Received 13 February 2014; Revised 11 April 2014; Accepted 12 April 2014; Published 30 April 2014

Academic Editor: Jairo Kenupp Bastos

Copyright © 2014 Zhi-Hui Ding et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. V. Jha, G. Garcia-Garcia, K. Iseki et al., “Chronic kidney disease: global dimension and perspectives,” The Lancet, vol. 382, no. 9888, pp. 260–272, 2013. View at Publisher · View at Google Scholar
  2. Y. Wang, Y. P. W. Wang, Y.-C. Tay, and D. C. H. Harris, “Progressive adriamycin nephropathy in mice: sequence of histologic and immunohistochemical events,” Kidney International, vol. 58, no. 4, pp. 1797–1804, 2000. View at Publisher · View at Google Scholar · View at Scopus
  3. H. Pavenstädt, W. Kriz, and M. Kretzler, “Cell biology of the glomerular podocyte,” Physiological Reviews, vol. 83, no. 1, pp. 253–307, 2003. View at Google Scholar · View at Scopus
  4. J. Zheng, J. Gong, A. Zhang et al., “Attenuation of glomerular filtration barrier damage in adriamycin-induced nephropathic rats with bufalin: an antiproteinuric agent,” Journal of Steroid Biochemistry and Molecular Biology, vol. 129, no. 3–5, pp. 107–114, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. N. Boute, “Erratum: NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome (Nature Genetics (2000) 24 (349–354)),” Nature Genetics, vol. 25, no. 1, p. 125, 2000. View at Google Scholar · View at Scopus
  6. G. Mollet, J. Ratelade, O. Boyer et al., “Podocin inactivation in mature kidneys causes focal segmental glomerulosclerosis and nephrotic syndrome,” Journal of the American Society of Nephrology, vol. 20, no. 10, pp. 2181–2189, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. E. Machuca, A. Hummel, F. Nevo et al., “Clinical and epidemiological assessment of steroid-resistant nephrotic syndrome associated with the NPHS2 R229Q variant,” Kidney International, vol. 75, no. 7, pp. 727–735, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. V. Agrawal, N. Prasad, M. Jain, and R. Pandey, “Reduced podocin expression in minimal change disease and focal segmental glomerulosclerosis is related to the level of proteinuria,” Clinical and Experimental Nephrology, vol. 17, no. 6, pp. 811–818, 2013. View at Publisher · View at Google Scholar
  9. V. K. Kapoor, “Natural toxins and their therapeutic potential,” Indian Journal of Experimental Biology, vol. 48, no. 3, pp. 228–237, 2010. View at Google Scholar · View at Scopus
  10. V. K. Vyas, K. Brahmbhatt, H. Bhatt, and U. Parmar, “Therapeutic potential of snake venom in cancer therapy: current perspectives,” Asian Pacific Journal of Tropical Biomedicine, vol. 3, no. 2, pp. 156–162, 2013. View at Publisher · View at Google Scholar
  11. K. Z. Zhu, Y. L. Liu, J. H. Gu, and Z. H. Qin, “Antinociceptive and anti-inflammatory effects of orally administrated denatured naja naja atra venom on murine rheumatoid arthritis models,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 616241, 10 pages, 2013. View at Publisher · View at Google Scholar
  12. C.-C. Hung, S.-H. Wu, and S.-H. Chiou, “Sequence characterization of cardiotoxins from Taiwan cobra: isolation of a new isoform,” Biochemistry and Molecular Biology International, vol. 31, no. 6, pp. 1031–1040, 1993. View at Google Scholar · View at Scopus
  13. S.-H. Chiou, R. L. Raynor, B. Zheng, T. C. Chambers, and J. F. Kuo, “Cobra venom cardiotoxin (cytotoxin) isoforms and neurotoxin: comparative potency of protein kinase c inhibition and cancer cell cytotoxicity and modes of enzyme inhibition,” Biochemistry, vol. 32, no. 8, pp. 2062–2067, 1993. View at Google Scholar · View at Scopus
  14. S.-H. Chiou, C.-C. Hung, H.-C. Huang, S.-T. Chen, K.-T. Wang, and C.-C. Yang, “Sequence comparison and computer modelling of cardiotoxins and cobrotoxin isolated from Taiwan cobra,” Biochemical and Biophysical Research Communications, vol. 206, no. 1, pp. 22–32, 1995. View at Publisher · View at Google Scholar · View at Scopus
  15. Y.-X. Liang, W.-J. Jiang, L.-P. Han, and S.-J. Zhao, “Peripheral and spinal antihyperalgesic activity of najanalgesin isolated from Naja naja atra in a rat experimental model of neuropathic pain,” Neuroscience Letters, vol. 460, no. 3, pp. 191–195, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. C.-M. Chien, S.-Y. Chang, K.-L. Lin, C.-C. Chiu, L.-S. Chang, and S.-R. Lin, “Taiwan cobra cardiotoxin III inhibits Src kinase leading to apoptosis and cell cycle arrest of oral squamous cell carcinoma Ca9-22 cells,” Toxicon, vol. 56, no. 4, pp. 508–520, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. L.-W. Chen, P.-H. Kao, Y.-S. Fu, S.-R. Lin, and L.-S. Chang, “Membrane-damaging activity of Taiwan cobra cardiotoxin 3 is responsible for its bactericidal activity,” Toxicon, vol. 58, no. 1, pp. 46–53, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Z. Wang, H. He, R. Han et al., “The protective effects of cobra venom from Naja naja atra on acute and chronic nephropathy,” Evidence-Based Complementary and Alternative Medicine, Article ID 478049, 17 pages, 20132013. View at Publisher · View at Google Scholar
  19. G. L. Dai, J. K. He, Y. Xie, R. Han, Z. H. Qin, and L. J. Zhu, “Therapeutic potential of Naja naja atra venom in a rat model of diabetic nephropathy,” Biomedical and Environmental Sciences, vol. 25, no. 6, pp. 630–638, 2012. View at Google Scholar
  20. V. W. Lee and D. C. Harris, “Adriamycin nephropathy: a model of focal segmental glomerulosclerosis,” Nephrology, vol. 16, no. 1, pp. 30–38, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. M. M. Bradford, “A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding,” Analytical Biochemistry, vol. 72, no. 1-2, pp. 248–254, 1976. View at Google Scholar · View at Scopus
  22. V. Agrawal, V. Marinescu, M. Agarwal, and P. A. McCullough, “Cardiovascular implications of proteinuria: an indicator of chronic kidney disease,” Nature Reviews Cardiology, vol. 6, no. 4, pp. 301–311, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Okuda, Y. Oh, H. Tsuruda, K. Onoyama, S. Fujimi, and M. Fujishima, “Adriamycin-induced nephropathy as a model of chronic progressive glomerular disease,” Kidney International, vol. 29, no. 2, pp. 502–510, 1986. View at Google Scholar · View at Scopus
  24. N. R. Shah and F. Dumler, “Hypoalbuminaemia—a marker of cardiovascular disease in patients with chronic kidney disease stages II–IV,” International Journal of Medical Sciences, vol. 5, no. 6, pp. 366–370, 2008. View at Google Scholar · View at Scopus
  25. T. Bertani, A. Poggi, and R. Pozzoni, “Adriamycin-induced nephrotic syndrome in rats. Sequence of pathologic events,” Laboratory Investigation, vol. 46, no. 1, pp. 16–23, 1982. View at Google Scholar · View at Scopus
  26. L. S. Milner, S. H. Wei, and M. T. Houser, “Amelioration of glomerular injury in doxorubicin hydrochloride nephrosis by dimethylthiourea,” Journal of Laboratory and Clinical Medicine, vol. 118, no. 5, pp. 427–434, 1991. View at Google Scholar · View at Scopus
  27. M. A. Mansour, H. A. El-Kashef, and O. A. Al-Shabanah, “Effect of captopril on doxorubicin-induced nephrotoxicity in normal rats,” Pharmacological Research, vol. 39, no. 3, pp. 233–237, 1999. View at Publisher · View at Google Scholar · View at Scopus
  28. N. Venkatesan, D. Punithavathi, and V. Arumugam, “Curcumin prevents adriamycin nephrotoxicity in rats,” British Journal of Pharmacology, vol. 129, no. 2, pp. 231–234, 2000. View at Google Scholar · View at Scopus
  29. K. P. G. Harris, M. L. Purkerson, J. Yates, and S. Klahr, “Lovastatin ameliorates the development of glomerulosclerosis and uremia in experimental nephrotic syndrome,” The American Journal of Kidney Diseases, vol. 15, no. 1, pp. 16–23, 1990. View at Google Scholar · View at Scopus
  30. M. Washio, F. Nanishi, K. Onoyama, S. Okuda, and M. Fujishima, “Effects of fish oil rich in eicosapentaenoic acid on focal glomerulosclerosis of adriamycin-induced nephropathy in rats,” Current Therapeutic Research—Clinical and Experimental, vol. 53, no. 1, pp. 35–41, 1993. View at Google Scholar · View at Scopus
  31. S. H. Wang, L. Wang, Y. Zhou et al., “Prevalence and control of dyslipidaemia among diabetic patients with microalbuminuria in a Chinese hospital,” Diabetes & Vascular Disease Research, vol. 10, no. 2, pp. 169–178, 2013. View at Google Scholar
  32. L. E. Schlanger, J. L. Bailey, and J. M. Sands, “Electrolytes in the Aging,” Advances in Chronic Kidney Disease, vol. 17, no. 4, pp. 308–319, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. N. Nagano, S. Miyata, S. Obana et al., “Sevelamer hydrochloride (Renagel), a non-calcaemic phosphate binder, arrests parathyroid gland hyperplasia in rats with progressive chronic renal insufficiency,” Nephrology Dialysis Transplantation, vol. 16, no. 9, pp. 1870–1878, 2001. View at Google Scholar · View at Scopus